Literature DB >> 9224127

Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases.

N J Wald1, H C Watt.   

Abstract

OBJECTIVE: To estimate the extent to which cigarette smokers who switch to cigars or pipes alter their risk of dying of three-smoking related diseases-lung cancer, ischaemic heart disease, and chronic obstructive lung disease.
DESIGN: A prospective study of 21520 men aged 35-64 years when recruited in 1975-82 with detailed history of smoking and measurement of carboxyhaemoglobin. MAIN OUTCOME MEASURES: Notification of deaths (to 1993) classified by cause.
RESULTS: Pipe and cigar smokers who had switched from cigarettes over 20 years before entry to the study smoked less tobacco than cigarette smokers (8.1 g/day v 20 g/day), but they had the same consumption as pipe and cigar smokers who had never smoked cigarettes (8.1 g) and had higher carboxyhaemoglobin saturations (1.2% v 1.0%, P < 0.001), indicating that they inhaled tobacco smoke to a greater extent. They had a 51% higher risk of dying of the three smoking related diseases than pipe or cigar smokers who had never smoked cigarettes (relative risk 1.51; 95% confidence interval 0.96 to 2.38), a 68% higher risk than lifelong non-smokers (1.68; 1.16 to 2.45), a 57% higher risk than former cigarette smokers who gave up smoking over 20 years before entry (1.57; 1.04 to 2.38), and a 46% lower risk than continuing cigarette smokers (0.54; 0.38 to 0.77).
CONCLUSION: Cigarette smokers who have difficulty in giving up smoking altogether are better off changing to cigars or pipes than continuing to smoke cigarettes. Much of the effect is due to the reduction in the quantity of tobacco smoked, and some is due to inhaling less. Men who switch do not, however, achieve the lower risk of pipe and cigar smokers who have never smoked cigarettes. All pipe and cigar smokers have a greater risk of lung cancer than lifelong non-smokers or former smokers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224127      PMCID: PMC2126967          DOI: 10.1136/bmj.314.7098.1860

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  23 in total

1.  Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress?

Authors:  J E Henningfield; K O Fagerstrom
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

2.  Pleasure, pain, and prophylaxis: olfaction (the neglected sense).

Authors:  R V Lee
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-07

3.  Prevalence of alternative forms of tobacco use in a population of young adult military recruits.

Authors:  Mark W Vander Weg; Alan L Peterson; Jon O Ebbert; Margaret Debon; Robert C Klesges; C Keith Haddock
Journal:  Addict Behav       Date:  2007-07-13       Impact factor: 3.913

4.  Effect on mortality of switching from cigarettes to pipes or cigars. Study underestimated difference in risk.

Authors:  B R O'Driscoll
Journal:  BMJ       Date:  1998-03-14

5.  BUPA and the tobacco industry. Chairperson of BUPA in Republic of Ireland is also chairperson of tobacco producer.

Authors:  F Howell
Journal:  BMJ       Date:  1998-03-14

Review 6.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

Review 7.  Non-cigarette tobacco and the lung.

Authors:  Michael Schivo; Mark V Avdalovic; Susan Murin
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

Review 8.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

9.  Smoky coal, tobacco smoking, and lung cancer risk in Xuanwei, China.

Authors:  Christopher Kim; Robert S Chapman; Wei Hu; Xingzhou He; H Dean Hosgood; Larry Z Liu; Hong Lai; Wei Chen; Debra T Silverman; Roel Vermeulen; Linwei Tian; Bryan Bassig; Min Shen; Yawei Zhang; Shuangge Ma; Nathaniel Rothman; Qing Lan
Journal:  Lung Cancer       Date:  2014-01-11       Impact factor: 5.705

Review 10.  Lung cancer: epidemiology, etiology, and prevention.

Authors:  Charles S Dela Cruz; Lynn T Tanoue; Richard A Matthay
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.